Longevity Health Holdings Inc.
XAGE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.52 | -3.20 | -0.14 | 0.00 |
| FCF Yield | -2.51% | -0.35% | -0.06% | -0.02% |
| EV / EBITDA | -16.71 | -156.24 | -1,163.51 | -65,490.57 |
| Quality | ||||
| ROIC | 121.59% | -19.41% | 208.67% | 8.46% |
| Gross Margin | 87.37% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.37 | 0.54 | 0.38 | 0.18 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -100.00% | -100.00% |
| Free Cash Flow Growth | 47.62% | -143.86% | -190.17% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -0.05 | 0.05 | -0.71 | -102.14 |
| Interest Coverage | -101.98 | -5.87 | -1.47 | -0.19 |
| Efficiency | ||||
| Inventory Turnover | 0.06 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -224,542.77 | -12,920.24 | -3,218.38 | 0.00 |